Pacira BioSciences Inc (NASDAQ: PCRX) stock closed at $19.09 on 12/4/24 after a major increase of 14.4%. Moreover, exceptionally high trading volume at 267% of normal accompanied the advance. The stock has risen 9.6% during […]
Marvell Technology Inc (NASDAQ: MRVL) stock closed at $118.15 on 12/4/24 after a major increase of 23.2%. Moreover, trading volume in this advance was exceptionally high at 523% of normal. The stock has risen 28.1% […]
IDT Corp (NYSE: IDT) has reported E.P.S. of $0.68 for its first fiscal quarter (ending October 31) versus $0.30 for the same period a year ago — an increase of 127%. For the latest four […]
Culp Inc. (NYSE: CULP) has reported E.P.S. of $-0.45 for its second fiscal quarter (ending October 31) versus $-0.19 for the same period a year ago. E.P.S. were $-1.68 for the latest four quarters through […]
On 12/4/24, Caesarstone Ltd (NASDAQ: CSTE) stock enjoyed a major increase of 11.9%, closing at $4.76. Moreover, this advance was accompanied by exceptionally high trading volume at 360% of normal. The stock has been weak […]
Extremely important negative changes in investment behavior have recently occurred for BCE Inc. (NYSE: BCE): negative upside/downside volume developed, and the stock fell on very heavy volume. BCE Inc. (NYSE: BCE). Notable negative changes in […]
For its second fiscal quarter (ending October 31), AeroVironment Inc (NASDAQ: AVAV) has reported a -59% decline in E.P.S. from $0.66 a year ago to $0.27 in the current quarter. For the latest four quarters […]
Capricor Therapeutics Inc (NASDAQ: CAPR) stock suffered a major decline of -15.9% on 12/3/24. The shares closed at $16.51. NORMAL trading volume accompanied the decline. The stock has declined -11.3% during the last week but […]
Extremely significant negative changes in Amedisys Inc (NASDAQ: AMED) investment behavior have recently occurred: negative upside/downside volume developed, and the stock fell on very heavy volume. Amedisys Inc (NASDAQ: AMED). Important negative changes in fundamentals […]
For its third fiscal quarter (ending October 31), SALESFORCE INC (NYSE: CRM) has reported a 27% increase in E.P.S. from $1.26 a year ago to $1.60 in the current quarter. E.P.S. were $6.15 for the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research